CLINICAL_TRIALS
withdrawal
· 2013-08-05
Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer [Phase 1]
Summary
Phase 1 cancer vaccine trial for metastatic or recurrent cancer has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Breast Cancer, Gastric Cancer | Phase 1 | Status: WITHDRAWN